Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, KalVista Pharmaceuticals Inc’s stock clocked out at $11.15, down -3.34% from its previous closing price of $11.54. In other words, the price has decreased by -$3.34 from its previous closing price. On the day, 0.83 million shares were traded. KALV stock price reached its highest trading level at $11.78 during the session, while it also had its lowest trading level at $11.04.
Ratios:
To gain a deeper understanding of KALV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.44 and its Current Ratio is at 10.44. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on January 31, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $19.
On January 07, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $30.
On December 18, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.BofA Securities initiated its Buy rating on December 18, 2024, with a $22 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Palleiko Benjamin L sold 6,669 shares for $11.97 per share. The transaction valued at 79,828 led to the insider holds 287,811 shares of the business.
Audhya Paul K. sold 2,394 shares of KALV for $23,988 on Feb 24 ’25. The CHIEF MEDICAL OFFICER now owns 102,940 shares after completing the transaction at $10.02 per share. On Feb 24 ’25, another insider, Yea Christopher, who serves as the CHIEF DEVELOPMENT OFFICER of the company, sold 1,918 shares for $10.02 each. As a result, the insider received 19,218 and left with 93,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KALV now has a Market Capitalization of 554577536 and an Enterprise Value of 307156928.
Stock Price History:
The Beta on a monthly basis for KALV is 0.39, which has changed by -0.0093250275 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, KALV has reached a high of $15.50, while it has fallen to a 52-week low of $7.30. The 50-Day Moving Average of the stock is 4.69%, while the 200-Day Moving Average is calculated to be 0.49%.
Shares Statistics:
It appears that KALV traded 453.35K shares on average per day over the past three months and 610920 shares per day over the past ten days. A total of 49.49M shares are outstanding, with a floating share count of 38.56M. Insiders hold about 22.44% of the company’s shares, while institutions hold 89.05% stake in the company. Shares short for KALV as of 1741910400 were 5836841 with a Short Ratio of 12.87, compared to 1739491200 on 5831280. Therefore, it implies a Short% of Shares Outstanding of 5836841 and a Short% of Float of 13.25.
